Ticker Notes
A collection of stock notes from around the web.
August 11, 2009
$30 Price Target on Human Genome Sciences
Notables Calls
notes
that Leerink has set a new price target of $30 on Human Genome Sciences due to the likely hood of positive Phase II trial data for BLISS-76.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment